 Cytomegalovirus years Rowe Weller colleagues human cytomegalovirus CMV complex structure replicative cycle low yield vitro species-specific cell-substrate requirement cellular molecular biologic analyses human CMV slow recombinant DNA monoclonal antibody technologies rapid changes long period latency wide range disease presentations epidemiologic medical insights clinical events iatrogenic immunosuppression transplantation cancer therapy result immunocompromise due human immunodeficiency virus infection understanding epidemiology CMV disease definition clinical spectrum Rapid diagnostic methods antiviral drugs vaccines CMV available impact agent nonimmunosuppressed aspects pathogenesis immune functions recrudescence possibility increased disease severity detectable immune defect availability new approaches issues functions host virus mechanism persistence